Sung Kee Chung
Pohang University of Science and Technology
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sung Kee Chung.
Journal of Biological Chemistry | 1999
Xiaonian Yang; Marco T. Rudolf; Mark Carew; Masako Yoshida; Volkmar Nerreter; Andrew M. Riley; Sung Kee Chung; Karol S. Bruzik; Barry V. L. Potter; Carsten Schultz; Stephen B. Shears
Ca2+-activated Cl− channels are inhibited by inositol 3,4,5,6-tetrakisphosphate (Ins(3,4,5,6)P4) (Xie, W., Kaetzel, M. A., Bruzik, K. S., Dedman, J. R., Shears, S. B., and Nelson, D. J. (1996) J. Biol. Chem. 271, 14092–14097), a novel second messenger that is formed after stimulus-dependent activation of phospholipase C (PLC). In this study, we show that inositol 1,3,4-trisphosphate (Ins(1,3,4)P3) is the specific signal that ties increased cellular levels of Ins(3,4,5,6)P4 to changes in PLC activity. We first demonstrated that Ins(1,3,4)P3 inhibited Ins(3,4,5,6)P4 1-kinase activity that was either (i) in lysates of AR4–2J pancreatoma cells or (ii) purified 22,500-fold (yield = 13%) from bovine aorta. Next, we incubated [3H]inositol-labeled AR4–2J cells with cell permeant and non-radiolabeled 2,5,6-tri-O-butyryl-myo-inositol 1,3,4-trisphosphate-hexakis(acetoxymethyl) ester. This treatment increased cellular levels of Ins(1,3,4)P3 2.7-fold, while [3H]Ins(3,4,5,6)P4 levels increased 2-fold; there were no changes to levels of other 3H-labeled inositol phosphates. This experiment provides the first direct evidence that levels of Ins(3,4,5,6)P4 are regulated by Ins(1,3,4)P3 in vivo, independently of Ins(1,3,4)P3 being metabolized to Ins(3,4,5,6)P4. In addition, we found that the Ins(1,3,4)P3 metabolites, namely Ins(1,3)P2 and Ins(3,4)P2, were >100-fold weaker inhibitors of the 1-kinase compared with Ins(1,3,4)P3 itself (IC50 = 0.17 μm). This result shows that dephosphorylation of Ins(1,3,4)P3 in vivo is an efficient mechanism to “switch-off” the cellular regulation of Ins(3,4,5,6)P4 levels that comes from Ins(1,3,4)P3-mediated inhibition of the 1-kinase. We also found that Ins(1,3,6)P3 and Ins(1,4,6)P3 were poor inhibitors of the 1-kinase (IC50 = 17 and >30 μm, respectively). The non-physiological trisphosphates,d/l-Ins(1,2,4)P3, inhibited 1-kinase relatively potently (IC50 = 0.7 μm), thereby suggesting a new strategy for the rational design of therapeutically useful kinase inhibitors. Overall, our data provide new information to support the idea that Ins(1,3,4)P3 acts in an important signaling cascade.
Carbohydrate Research | 1996
Ian D. Spiers; Christopher J. Barker; Sung Kee Chung; Young-Tae Chang; Sally Freeman; John M. Gardiner; Peter H. Hirst; Peter A. Lambert; Robert H. Michell; David R. Poyner; Carl H. Schwalbe; Anthony W. Smith; Kevin R.H. Solomons
The first syntheses of the natural products myo-inositol 1,2,3-trisphosphate and (+/-)-myo-inositol 1,2-bisphosphate are described. The protected key intermediates 4,5,6-tri-O-benzoyl-myo-inositol and (+/-)-3,4,5,6-tetra-O-benzyl-myo-inositol were phosphorylated with dibenzyl N,N-di-isopropylphosphoramidite in the presence of 1H-tetrazole and subsequent oxidation of the phosphite. The crystal structures of the synthetic intermediates (+/-)-1-O-(tert-butyldiphenylsilyl)-2,3,O-cyclohexylidene-myo-inos itol and (+/-)-4,5,6-tri-O-benzoyl-1-O-(tert-butyldiphenylsilyl)-2,3-O-cycl ohexylidene- myo-inositol are reported. myo-Inositol 1,2,3-trisphosphate, (+/-)-myo-inositol 1,2-bisphosphate, and all isomeric myo-inositol tetrakisphosphates were evaluated for their ability to alter HO. production in the iron-catalysed Haber-Weiss reaction. The results demonstrated that a 1,2,3-grouping of phosphates in myo-inositol was necessary for inhibition, also that (+/-)-myo-inositol 1,2-bisphosphate potentiated HO. production. myo-Inositol 1,2,3-trisphosphate resembled myo-inositol hexakisphosphate (phytic acid) in its ability to act as a siderophore by promoting iron-uptake into Pseudomonas aeruginosa.
Bioorganic & Medicinal Chemistry Letters | 2010
Jeong Ju Park; Ji Hyung Lee; Kyung Chang Seo; Gabriel Bricard; Manjunatha M. Venkataswamy; Steven A. Porcelli; Sung Kee Chung
KRN7000 is an important ligand identified for CD1d protein of APC, and KRN7000/CD1d complex can stimulate NKT cells to release a broad range of bioactive cytokines. In an effort to understand the structure-activity relationships, we have carried out syntheses of 26 new KRN7000 analogues incorporating aromatic residues in either or both side chains. Structural variations of the phytosphingosine moiety also include varying stereochemistry at C3 and C4, and 4-deoxy and 3,4-dideoxy versions. Their biological activities are described.
Journal of the American Chemical Society | 2011
Pooja Arora; Manjunatha M. Venkataswamy; Andres Baena; Gabriel Bricard; Qian Li; Natacha Veerapen; Rachel M. Ndonye; Jeong Ju Park; Ji Hyung Lee; Kyung Chang Seo; Amy R. Howell; Young-Tae Chang; Petr A. Illarionov; Gurdyal S. Besra; Sung Kee Chung; Steven A. Porcelli
Structural variants of α-galactosylceramide (αGC) that activate invariant natural killer T cells (iNKT cells) are being developed as potential immunomodulatory agents for a variety of applications. Identification of specific forms of these glycolipids that bias responses to favor production of proinflammatory vs anti-inflammatory cytokines is central to current efforts, but this goal has been hampered by the lack of in vitro screening assays that reliably predict the in vivo biological activity of these compounds. Here we describe a fluorescence-based assay to identify functionally distinct αGC analogues. Our assay is based on recent findings showing that presentation of glycolipid antigens by CD1d molecules localized to plasma membrane detergent-resistant microdomains (lipid rafts) is correlated with induction of interferon-γ secretion and Th1-biased cytokine responses. Using an assay that measures lipid raft residency of CD1d molecules loaded with αGC, we screened a library of ∼200 synthetic αGC analogues and identified 19 agonists with potential Th1-biasing activity. Analysis of a subset of these novel candidate Th1 type agonists in vivo in mice confirmed their ability to induce systemic cytokine responses consistent with a Th1 type bias. These results demonstrate the predictive value of this novel in vitro assay for assessing the in vivo functionality of glycolipid agonists and provide the basis for a relatively simple high-throughput assay for identification and functional classification of iNKT cell activating glycolipids.
Bioorganic & Medicinal Chemistry Letters | 2009
Kiyomi Tsuji; Shigeru Satoh; Susumu Mitsutake; Itsuo Murakami; Jeong Ju Park; Qian Li; Young-Tae Chang; Sung Kee Chung; Yasuyuki Igarashi
In this Letter, we assessed newly synthesized sphingolipid analogs as ligands for peroxisome proliferator-activated receptor (PPAR)alpha, PPARbeta or PPARgamma, using a dual-luciferase reporter system. We tested 640 sphingolipid analogs for ligand activity. As a result, seven types: A9, B9, C9, C50, F66, G66 and H66, were found to show agonistic activities for PPARs.
Molecules | 2000
Young Mee Kim; Suk Jin Song; Tae Woo Kwon; Sung Kee Chung
Cyclohexa-2,4-diene-1-one sulfone derivate undergoes ring cleavage to afford bis-amides containing a diene moiety on irradiation with visible light in the presence of various diamines.
Chemical Communications | 2009
Kyung Chang Seo; Young Geol Kwon; Dae Hee Kim; In Sook Jang; Jin Won Cho; Sung Kee Chung
Chemoenzymatic syntheses of several NDP-carba-sugars have been successfully carried out, and these essential cofactor analogues are expected to be selective inhibitors of glycosyltransferase enzymes.
Synthetic Communications | 1999
Young Mee Kim; Tae Woo Kwon; Sung Kee Chung; Michael B. Smith
Abstract Diethyl ethoxymethylenemalonate (EMME) is unexpectedly converted into diethyl 2-(1,1 -dialkyl and diarylmethyl) malonate derivatives by a classical Grignard reaction. Addition of organocuprates to EMME gave diethyl 2-(l-ethoxyalkyl) malonate derivatives. The yields range from 42-63%.
Bioorganic & Medicinal Chemistry Letters | 1997
Derek H. R. Barton; Sung Kee Chung; Young Mee Kim; Tae Woo Kwon
Abstract 2,4,6-Trimethylcyclohexa-2,4-dien-1-one derivatives undergo ring cleavage to furnish symmetrical amides on irradiation with visible light in the presence of various α,ω-diamines. Five different symmetrical amides containing a substituted diene moiety were synthesized in 65–85% yield.
Bioorganic & Medicinal Chemistry Letters | 2000
Tae Woo Kwon; Young Mee Kim; Suk Jin Song; Yong Uk Kwon; Sung Kee Chung
Thiophenyl substituted cyclohexa-2,4-dien-1-ones were synthesized and photolyzed in the presence of various amines to afford the amides containing diene moeties via the ketene intermediate under visible light irradiation at 38 degrees C.